Despite a large body of research documenting cannabis’ effectiveness in treating epilepsy, there has yet to be a cannabis-based anti-seizure medication introduced on the U.S. pharmaceutical market – until this week. On Monday, the U.S. Food and Drug Administration approved a epilepsy drug utilizing plant-derived cannabidiol (CBD), a common non-psychoactive …
Read More »